Keyphrases
Glioblastoma
89%
Brain Tumor
74%
Tumor
72%
Temozolomide
59%
Brain Metastases
48%
Awake Craniotomy
46%
Glioma
44%
Magnetic Resonance Imaging
39%
Microbubbles
32%
Overall Survival
31%
Glioma Model
31%
Resection
31%
Low-grade Glioma
28%
Elderly Patients
26%
Rodents
26%
Glioblastoma multiforme
25%
Glioblastoma Cells
22%
Postoperative Seizure
22%
High-grade Glioma
22%
N-methyl-D-aspartate Receptor (NMDAR)
21%
Newly Diagnosed Glioblastoma
20%
Radiation Therapy
19%
Length of Stay
19%
Surgical Resection
19%
Risk Factors
19%
5-Aminolevulinic Acid (5-ALA)
19%
Neuroinflammation
17%
Gliadel
17%
Tumor Resection
17%
Patient Survival
17%
U87 Glioma Cells
17%
Bevacizumab
17%
Primary Central Nervous System Lymphoma (PCNSL)
16%
Closed Head Injury
16%
P-selectin
16%
Peripheral Benzodiazepine Receptor
16%
Tumor Treating Fields
16%
Laboratory Investigation
16%
Lipid-coated Microbubbles
16%
Quantitative MRI
16%
Female Neurosurgeons
16%
Microcapsules
16%
Lung Cancer Brain Metastases
16%
Endostatin
16%
European Women
16%
Human Glioma
16%
PK11195
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Radiation Necrosis
16%
Flow Cytometry
16%
Medicine and Dentistry
Neoplasm
100%
Ganglioglioma
66%
Intracranial Tumor
57%
Craniotomy
52%
Glioblastoma
51%
Brain Metastasis
45%
Magnetic Resonance Imaging
35%
Biopsy Technique
24%
Temozolomide
21%
Overall Survival
19%
Apoplexy
19%
Cancer Surgery
18%
Pituitary Tumour
18%
Epileptic Seizure
17%
Elderly Patient
17%
Aminolevulinic Acid
17%
Melanoma
17%
Carmustine
16%
Brain Ventricle Peritoneum Shunt
16%
Primary Central Nervous System Lymphoma
16%
Brain Biopsy
16%
Infarction
16%
Radiation Necrosis
16%
Neurosurgery
16%
Transsphenoidal Surgery
16%
Endoscopic Endonasal Surgery
14%
Neuro-Oncology
14%
Flow Cytometry
14%
Metastatic Carcinoma
13%
Edema
12%
Tumor Microenvironment
12%
Macroadenoma
11%
Cohort Analysis
11%
Low Drug Dose
10%
Intracranial Pressure
10%
Epidermal Growth Factor Receptor
10%
Radiation Therapy
10%
Sequela
10%
Pituitary Gland
10%
Astrocyte
10%
Recurrent Disease
9%
Brain Development
9%
Quality of Life
9%
Neurosurgical Oncology
9%
Karnofsky Performance Status
8%
Multivariate Analysis
8%
Isocitrate Dehydrogenase 1
8%
Tumor Infiltrating Lymphocyte
8%
General Anesthesia
8%
Breast Adenocarcinoma
8%
